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The human microbiome, often referred to as the ‘second genome’, encompasses up to 100-fold more genes than
the host genome. In contrast to the human genome, the microbial genome is flexible and amenable to change
during the host’s lifetime. As the composition of the microbial metagenome has been associated with the
development of human disease, the mechanisms controlling the composition and function of the metagenome are
of considerable interest and therapeutic potential. In the past few years, studies have revealed how the host
immune system is involved in determining the microbial metagenome, and, in turn, how the microbiota regulates
gene expression in the immune system. This species-specific bidirectional interaction is required for homeostatic
health, whereas aberrations in the tightly controlled regulatory circuits that link the host immunogenome and the
microbial metagenome drive susceptibility to common human diseases. Here, we summarize some of the major
principles orchestrating this cross-talk between microbial and host genomes, with a special focus on the interaction
between the intestinal immune system and the gut microbiome. Understanding the reciprocal genetic and
epigenetic control between host and microbiota will be an important step towards the development of novel
therapies against microbiome-driven diseases.The bi-directional interaction between microbial
and host genomes
The genomic revolution has transformed our ability to
study the composition and evolution of genomes. These
technical advances have enabled comprehensive analysis
of the human genome and of the genomes of all indigen-
ous commensal microorganisms, collectively referred to
as the microbial metagenome. The human microbiome
is acquired after birth and is shaped throughout an indi-
vidual’s lifetime. The individual's diet [1], household
characteristics [2], exposure to xenobiotics [3], and the
time of day [4] are among the environmental factors that
most strongly influence the metagenome.
The microbiota reaches a stable configuration at age 2–
3 years (Table 1). The species and strain composition of
the microbiota are generally maintained over the following
years, while undergoing fluctuations according to the en-
vironmental factors mentioned above. The community* Correspondence: eran.elinav@weizmann.ac.il
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microbiota differ markedly among individuals [5, 6]. The
human microbiota is dominated by bacteria belonging to
two phyla, Bacteroidetes and Firmicutes [7]. A core set of
more than 50 distinct bacterial species is found in nearly
all human individuals [8]. A corresponding functional core
likewise exists and is encoded by the minimal human gut
metagenome, which is required for the correct function of
the intestinal ecosystem. The core functional features of
the minimal human gut metagenome include functions
important for proper interaction between the host and its
microbiome, such as degradation of complex polysaccha-
rides and synthesis of short-chain fatty acids [8].
The composition of the gut metagenome is highly rele-
vant for human health and disease, as illustrated by find-
ings pertaining to the etiology of obesity (Table 1).
Human energy homeostasis is determined by a set of
known human genes, yet these genes account for only a
small amount of the variability in energy homeostasis
that exists between humans. In addition to the human
genes, the gut microbiota has been suggested to affectdistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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Table 1 Postnatal development of the microbiota and effects of obesity and IBD
Physiologic or pathologic status Involved taxa Phenotypic manifestation References
Early microbial colonization Breastfed individuals: low species diversity,
most abundant phyla are Actinobacteria and
Firmicutes. Formula-fed individuals: low species
diversity, most abundant phyla are Actinobacteria
and Bacteriodetes. All individuals: facultative
anaerobic bacteria including Staphylococcus
species, Streptococcus species, Escherichia coli
and other Enterobacteriaceae are thought to be
the first colonizers of the gut
Several factors can control microbial colonization
after birth, including delivery mode, hygiene,
feeding, and antibiotics use
[122, 123]
Weissella, Leuconostoc, Staphylococcus,
Streptococcus, and Lactococcus species
predominate
Human colostrum and breast milk contains more
than 700 species of bacteria, including species
typically found in the oral cavity
[124]
Major phyla: Bacteriodetes and Firmicutes From 18 months, the diet influences the bacterial





The newborn gut microbiota is similar to the
maternal skin and vaginal microbiota
[123]
Cesarean‐born infants featured lower relative
abundance of Bifidobacterium and Bacteroides
species compared to vaginally born children
The delivery mode determines early colonization
through modulating the type of bacteria that
the child is exposed to at birth
[126, 127]
Obesity Reduced abundance of Bacteroidetes species in
obese individuals
Transfer of microbiota with a composition
characteristically found in obese mice into
germ-free mice results in weight gain
[12]
Firmicutes were dominant in normal-weight
individuals and in those with obesity, but
substantially less abundant in individuals who
had undergone gastric bypass surgery, who
had a proportional increase in abundance of
Gammaproteobacteria. Prevotellaceae were
highly enriched in individuals with obesity
Treatment with antibiotics results in weight gain [128]
Increased relative abundance of Faecalibacterium
prausnitzii in children with obesity
Treatment of children with antibiotics before
the age of 6 months results in weight gain
[129]
Bacteroides and Clostridium were the most
prevalent genera
Colonization of adult germ-free mice with a
microbial community harvested from the distal
gut of conventionally raised mice produces a
dramatic increase in body fat content within
10–14 days
[130]
The relative abundance of Bacteroidetes in obese
mice is 50 % lower than that in normal-weight
mice, whereas the relative abundance of
Firmicutes is proportionally higher
A low-calorie, fat-restricted or
carbohydrate-restricted diet leads to an increase
in relative abundance of Bacteroidetes
[13]
IBD Higher relative abundance in CD: Proteobacteria,
Fusobacterium, Haemophilus influenzae and other
Haemophilus species, Neisseriaceae, E. coli.
Lower relative abundance in CD: Bacteroides,
Bifidobacterium, and Blautia
The intestinal microbiota is disturbed in children
with IBD
[115, 131]
CD Crohn’s disease, IBD inflammatory bowel disease, UC ulcerative colitis
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harvest from the diet [9, 10]. Obesity is characterized by
lower bacterial diversity, along with alterations in the bac-
terial metagenome [11, 12]. Similarly, the development of
obesity in leptin-deficient mice (ob/ob) coincides with
phylum-level changes in the gut microbiome, with obese
mice having reduced relative abundance of Bacteroidetes
and increased relative abundance of Firmicutes [13].
Advances in genomics have also led to a revolution in
the study of another factor that shapes the microbiome:
the host immune system. Basic and clinical immunologyhave been redefined by developments in next-generation
sequencing and genome editing techniques [14]. Our
molecular understanding in this field now ranges from
transcriptome profiles of innate and adaptive immune
cells to epigenetic regulation of cytokine expression and
the effect of genetic mutations on immune-mediated
diseases.
Combining the techniques of metagenomics and
immunogenomics has led to an understanding of how
the microbiome influences the development and activity
of the immune system, and is in turn itself shaped by
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ies in mouse models have revealed that impairment in
this genomic cross-talk is closely associated with the
pathogenesis of numerous multi-factorial diseases, which
include infectious diseases, inflammatory and auto-
immune disorders, metabolic diseases, cancer, and even
neurodegenerative and aging-related disorders [16]. As
such, advances in genomic research have important im-
plications for human disease and are rapidly expanding
the horizons of immunology towards fields and disorders
never studied before, which is expected to result in the
identification of innovative and personalized genomic-
based immune-mediated and microbiome-mediated
therapeutic strategies. To facilitate this development, a
basic understanding of the mechanisms by which host
and microbial genomes influence one another is critic-
ally important. In the following sections, we review some
of the common principles by which the microbiota influ-
ences the host genome and by which host immunoge-
nomics, in turn, control the microbiome. We also point
out the largest gaps that remain in our knowledge of the
mechanisms underlying this metagenomic cross-talk and
discuss future avenues in this very young field of study.
Genomic control of the host by the microbiome
The microbiota has emerged as a central factor that
influences host gene expression at all body sites that fea-
ture commensal colonization, such as the skin, respira-
tory tract, gastrointestinal tract, and the urogenital
system. Generally, the microbiota can exert its gene
regulatory influence either directly through the exposure
of the host to live microorganisms or components of mi-
crobial cells [17], or indirectly through the secretion of
metabolites [18]. However, whether an observed effect is
due to microbial antigens or metabolites has not been
elucidated in the majority of cases. Below, we first high-
light the general principles whereby the microbiota in-
fluences host gene expression at different body sites,
with a focus on the gastrointestinal tract. We then con-
centrate on the mechanisms of gene regulation in cells
of the immune system and discuss examples of how the
microbiota influences immune cell differentiation and
function at the levels of transcription, DNA methylation,
and histone modification.
The microbiome as a regulator of host gene expression
The notion that the activity of commensal microorgan-
isms may influence genomic organization and gene regu-
lation of the mammalian host gained momentum about
a decade ago, when studies of intestinal tissue using
DNA microarrays found major changes in gene expres-
sion between germ-free mice and mice colonized with
members of the commensal microbiota [19, 20].
Colonization by a single commensal bacterium modifiesgene expression in a large variety of physiological pro-
cesses, ranging from nutrient metabolism and tissue
development to immune system function and antimicro-
bial activity [19]. Similarly, even a single enteric virus,
upon introduction into a germ-free setting, dramatically
shapes the global gene expression profile of the intestine
[21]. When entire microbial communities are introduced
into germ-free mice, transcriptional responses to micro-
bial colonization can be observed all along the gastrointes-
tinal tract [22] and are specific for different cellular
compartments [23]. Similarly, upon microbial colonization
after birth, intestinal gene expression undergoes dramatic
reprogramming, which is partially dependent on microbial
sensing receptors of the innate immune system [22, 24].
This observation suggests that successive stages of com-
mensal colonization after birth are involved in shaping
gene regulatory processes during intestinal maturation
(Fig. 1). These studies support the notion of a 'super-
organism' in which eukaryotic and prokaryotic genomes
cross-regulate each other [25]. Of note, the transcriptional
response to microbial colonization is in part species-
specific, as, for instance, gene regulation differs between
mice and zebrafish that have undergone reciprocal micro-
biota transplantation [26].
Despite the enormous influence of intestinal microbial
colonization on gene regulation processes in the intes-
tine and in other systems [27–29] the mechanisms medi-
ating this transcriptional reprogramming remain largely
elusive. The first insights on these mechanisms came
from studies focusing on selected examples of the mi-
crobial effects on the host epigenome [30]. The methyla-
tion levels of the gene encoding Toll-like receptor 4
(Tlr4) were found to be lower in germ-free mice, which
indicates that commensal bacteria may exert their gene
regulatory effect through epigenetic modifications [31].
Furthermore, mice with a conditional deletion of the his-
tone deacetylase 3 (Hdac3) gene in intestinal epithelial
cells developed aberrations in intestinal barrier function,
loss of Paneth cells, and enhanced susceptibility to intes-
tinal inflammation [32]. These aberrations depend on
microbiota-derived signals, as germ-free mice lacking in-
testinal Hdac3 do not have the same phenotype. When
the microbiota of Hdac3-deficient mice was transferred
to Hdac3-sufficient germ-free mice, intestinal inflamma-
tion was not observed, which indicates that an intact
microbiota-Hdac3 axis is required for intestinal barrier
maintenance.
Seminal work by Camp et al. [33] indicated that the mod-
ulatory effect of the microbiota on intestinal gene expres-
sion happens independently of the spatial organization of
nucleosome-depleted accessible chromatin (Fig. 1). Germ-
free mice had a chromatin accessibility landscape similar to
that of conventionally raised mice or germ-free mice into
which normal commensal microbes had been introduced.
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Fig. 1 Effects of the microbiota on host gene regulation. Examples of epigenetic and transcriptional changes induced by commensal colonization
in the intestine. Arrows denote bacterial signals involved in the genetic reprogramming of immune cell subsets and intestinal epithelial cells.
Question marks indicate unknown microbial signals involved in the regulation of gene expression in macrophages, innate lymphoid cells, and
intestinal epithelial cells. Th17 T helper 17
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on intestinal gene regulation occur through distinct signal-
ing events that influence transcription factor binding to
open chromatin. Identifying these signaling events may un-
ravel the pathways utilized by the host tissue to assess the
microbial colonization status and appropriately respond by
modifying its transcriptome.
Together, these first studies analyzing the regulatory
mechanisms underlying the genomic cross-talk between
microbiome and host genome indicate that epigenetic
modification of gene expression through the microbiome
might involve multiple non-redundant pathways that
integrate microbial signals into appropriate host transcrip-
tional responses. Deciphering the mechanisms underlying
microbiome-regulated gene expression could complement
advances in our understanding of non-genomic processes
by which the microbiota influences epithelial function, in-
cluding glycosylation [34] and cargo sorting [35], which
have been reported in the past couple of years.
Microbiome-mediated gene regulation in the immune
system
The influence of the microbiota on genetic and epigenetic
regulation of gene expression in the host is especially ap-
parent in the immune system, both in homeostatic devel-
opment and function of the system and in disease. In a
human study that correlated the mucosal microbiome
composition with host gene expression in the pelvic pouchof patients with inflammatory bowel disease (IBD), the
strongest associations between microbes and host gene
expression were found in pathways of the innate and
adaptive immune system, most prominently in cytokine
pathways and the complement system [36]. This finding
points toward a critical role for the immune system in
microbiome-mediated genomic regulation of the host. In-
deed, upon microbial colonization of germ-free mice,
major transcriptional induction of innate and adaptive
immune genes occurs as early as 4 days after microbial in-
oculation, and includes activation of expression of anti-
microbial peptides, lineage transcription factors of T cells,
cytokines, and molecules involved in antigen presentation
[37]. Microbial colonization thus has a major role in the
regulation of gene expression in immune cells [17], and
the first mechanisms by which commensal bacteria
regulate immunogenomics have begun to be unraveled
[18, 38, 39]. Whereas many reviews have highlighted
the role of the microbiota in shaping immune system
development and function [16], here we focus specific-
ally on the gene regulatory aspects of the microbiota
in the immune system (Table 2).
Myeloid cells of the intestinal mucosa are among the
first line of innate host defense against invading bacteria
and thus require rapid transcriptional responses against
changes in microbial colonization. Examples of such
regulation include the induction of expression of pro-
inflammatory genes, such as genes encoding type I
Table 2 Examples of reprogramming of the immunogenome by the microbiota
Cell type Influence Microbial signal(s) References
Macrophages Deposition of activating histone marks, enhanced cytokine expression Unknown [40, 132]
Macrophages HDAC inhibition, reduced cytokine expression Butyrate [41]
Regulatory T cells HDAC inhibition, acetylation of FoxP3 CNS1 region, induction of proliferation,
upregulation of Uhrf1
Butyrate [42–45]
T helper 17 cells Transcriptional reprogramming through epithelially produced SAA1 and SAA2 Epithelial attachment [47, 48]
Neutrophils Induction of neutrophil aging, steady-state granulopoiesis, stimulation of
migration through SAA1 and SAA2
TLR ligands [133–135]
Innate lymphoid cells Transcriptional reprogramming, cytokine induction Unknown [133–135]
Natural killer T cells Mucosal recruitment via CXCL16, cytokine production Glycosphingolipids [52, 136, 137]
γδ T cells Transcriptional reprogramming Unknown [51]
HDAC histone deacetylase, TLR Toll-like receptor
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microbial colonization [40]. These effects are mediated
at least in part through the deposition of trimethylation
marks on histone H3 at the transcriptional start sites of
these genes, which renders them transcriptionally more
active [40] (Fig. 1). Conversely, the microbial short-chain
fatty acid butyrate downregulates pro-inflammatory gene
expression in intestinal macrophages through inhibition
of histone deacetylation [41].
Short-chain fatty acids also mediate transcriptional
control in regulatory T cells [42–44]. Butyrate increases
the number of peripheral regulatory T cells through in-
hibition of histone deacetylation in intronic enhancer se-
quences of the FoxP3 locus [43, 44], which encodes the
lineage transcription factor of regulatory T cells. Conse-
quently, treatment with butyrate ameliorated T-cell-
dependent colitis development in mice. In addition to
histone acetylation, DNA methylation also seems to have
a role in regulatory T-cell homeostasis in response to in-
testinal microbial colonization. The microbiota induces
the expression of the gene encoding the DNA methyla-
tion adaptor protein UHRF1 (Uhrf1) [45]. The expres-
sion of this protein is necessary for the maintenance of
proper DNA methylation in colonic regulatory T cells,
as well as for their proliferation and function (Fig. 1).
Another T-cell subset strongly influenced by the
microbiota is the T helper 17 (Th17) lineage [46]. Epithe-
lial attachment of intestinal bacteria drives transcrip-
tional reprogramming of intestinal epithelial cells, which
in turn secrete mediators such as serum amyloid A1 and
serum amyloid A2 (which are encoded by Saa1 and
Saa2, respectively) to regulate gene expression in Th17
cells resident in the lamina propria [47, 48]. Although
the exact mechanisms underlying this transcriptional
reprogramming remain to be fully understood, this
finding demonstrates that the microbiota programs
expression of host immune system genes not only
through secreted metabolites, but also through biogeo-
graphical localization and attachment.One of the most prominent yet poorly understood ex-
amples of microbial regulation of host immune cell gene
expression is found in innate lymphoid cells (ILCs). ILCs
are found at mucosal surfaces of the body and respond
to microbial challenges by producing cytokines. Accord-
ing to the type of cytokines produced, one can distin-
guish between ILCs type 1, 2, and 3. Type 3 ILCs
respond to intestinal microbial colonization through the
production of interleukin (IL)-22 [49] and ILCs from
germ-free mice or antibiotic-treated mice fail to produce
this cytokine, which is important for intestinal barrier
function and host defense against enteric pathogens
[50]. The microbial signals that mediate gene expression
in ILCs, including those that induce IL-22 expression,
remain unknown (Fig. 1).
Another instance of close cross-talk between the
microbiota and immune cells has been found in mucosal
γδ T cells and natural killer T (NKT) cells. These cells,
albeit expressing a T-cell receptor, have some character-
istics of innate immune cells, such as rapid cytokine se-
cretion in response to conserved classes of stimuli. The
microbiota reprograms the transcriptome of intraepithe-
lial γδ T cells, including reprogramming of the expres-
sion of antimicrobial peptides [51]. Furthermore,
commensal microbiota colonization during the neonatal
period in mice decreased CpG methylation in the 5' re-
gion of the gene encoding the chemokine CXCL16 [52].
The resultant decreased levels of Cxcl16 expression pro-
tected the mice from enhanced mucosal accumulation of
NKT cells in the lung and gastrointestinal tract. As a
consequence of ameliorated NKT cell recruitment, bowel
inflammation and allergic asthma were mitigated by
neonatal colonization [52].
These examples indicate that the regulatory effect of the
microbiota on host immunogenomics and epigenomics is
a pleiotropic phenomenon with considerable influence on
inflammatory processes in health and disease (Table 2).
Although most studies examining the influence of the
microbiome on immune system function have focused on
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body surfaces feature similar phenomena, including the
skin [53] and lung [54]. Further understanding of the
mechanisms by which commensal bacteria and their prod-
ucts orchestrate immune cell gene expression will be in-
strumental to move this young field of study forward to
eventually harness the new insights for therapeutic
purposes.
Genomic control of the microbiome by the host
Owing to the enormous effect of the microbiome on
host gene expression and the resultant effect on human
health, identifying the mechanisms by which bacterial
communities are assembled and structured is of substan-
tial interest [55, 56]. As discussed above, two main fac-
tors are responsible for the determination of an
individual’s microbiome: diet and genetics. Although the
diet seems to have a dominating effect and exerts this ef-
fect rapidly within days [57, 58], studies performed over
the past decade underline the critical role of host genet-
ics in shaping the metagenome, which we describe
below. We then discuss examples from animal studies that
illustrate mechanisms by which the immune system gen-
ome is involved in shaping the microbial metagenome.
Effect of the host genome on the microbiome
A systematic study focusing on environmental factors
and host genetic factors that together shape the complex
microbial ecosystem showed that host genetics shape the
diversity of the microbiome in mice [59]. In humans, the
study of monozygotic twins sharing one genotype is a
useful approach for evaluating a phenotype of interest. A
study of monozygotic twins discovered that the micro-
biota is significantly more similar between twins than
between unrelated individuals [60, 61]. Interestingly,
host genetics and environmental factors may differen-
tially influence distinct members of the microbiota, as
the abundances of certain taxa, such as Christensenella-
ceae, is more highly correlated within monozygotic than
within dizygotic twin pairs, whereas the abundance of
other bacterial taxa, such as Bacteroidetes, seems to be
mainly shaped by environmental factors [61, 62]. In
addition to bacteria, monozygotic twins were shown to
have more highly concordant gut archaea profiles, in-
cluding those of the methanogen Methanobrevibacter
smithii, than dizygotic twins [63].
On the basis of the association of certain host ge-
nomes with the abundance levels of microbial taxa [59],
studies have been performed to identify regions of the
genome that are responsible for these associations. A
genetic linkage study examined a cross between the
C57BL/6 J inbred mouse strain and an ICR/HaJ-derived
outbred line to determine significant associations
between host genomic variability and microbiotacomposition [59]. Eighteen quantitative trait loci
(QTLs) of the host showed significant linkage with the
relative abundances of specific microbial taxa. These
host loci were shown to control individual microbial
species, groups of related taxa, or groups of distantly
related microorganisms and contained genes involved
in immune signaling, such as Irak3, Lyz1, Lyz2, Ifng,
and Il22 [59]. Another genetic linkage study used a
genetic resource based on a mouse inbred line, which is
commonly used to study differences in susceptibility to
obesity and other metabolic traits [64], to discover
QTLs that influence gut microbial composition [65].
Additional genome sequencing in the QTL regions un-
covered candidate genes that could account for the
variation in microbiota composition. For example, a
QTL located on chromosome 15, harboring the candi-
date gene Irak4, had a significant association with Rike-
nellaceae, whereas a QTL mapped on chromosome 12,
harboring the candidate gene Tgfb3, had an effect on
Prevotellaceae. Another QTL region on chromosome 4,
located in a region rich in interferon genes, was associ-
ated with variation in the diversity and abundance of
Bacteroides [65]. A 2015 study extended our insight
into genomic control of the microbiome in humans by
analyzing the microbial composition at 15 different
body sites and their association to the host genome
[66]. Interestingly, the strongest associations were
driven by immune-pathway-related genes [66]. These
studies strongly implicate the immune system as a major
causative element in the determination of a host-specific
microbiome and suggest that genomic variations in im-
mune genes underlie, at least in part, inter-individual dif-
ferences in microbiota composition.
Importantly, this inter-individual variability bears im-
mediate relevance for inflammatory disease. For in-
stance, abnormal interactions between the host and the
microbiome are implicated in the pathogenesis of IBD.
IBD is associated with substantial alterations in micro-
biome composition [67–69]. In the past few years, mul-
tiple host genetic loci associated with increased
susceptibility to IBD were identified. To determine
whether human genetic factors underlie the shifts in mi-
crobial populations that have been observed in a subset
of patients with IBD, several studies have focused on the
effect of known risk alleles for IBD on metagenomic sta-
bility. Of these, the innate immune receptor NOD2 and
the autophagy-related protein ATG16L1 were signifi-
cantly associated with shifts in microbial composition
[70–73]. The relative abundances of several taxonomic
groups, such as Faecalibacterium and Escherichia, were
associated with NOD2 and ATG16L1 genotypes and dis-
ease phenotype. These results support the hypothesis
that both genetic factors and disease manifestation drive
substantial shifts in metagenomic composition.
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immune system
What are the signaling pathways and effector mecha-
nisms by which the host influences microbial
colonization? In line with the genetic linkage studies dis-
cussed above, the antimicrobial activity of the immune
system is a prime candidate for such activity, and mice
with global deficiencies in the innate and adaptive arms
of the immune system have been reported to harbor an
altered microbiota composition [74]. The innate immune
system is the first line of host defense against microbial
pathogens. It functions through the sensing of microor-
ganisms by innate immune receptors, which subse-
quently trigger an immune effector response. Innate
immune sensing is also required for the activation of
adaptive immunity, which is driven by antigen-specific T
and B cells. In this section, we summarize some exam-
ples of findings that highlight the mechanisms by which
the innate and adaptive immune responses shape the
metagenome, then briefly discuss how diseases of the
immune system affect the microbiome.
Innate immunity
Cells of the innate immune system express a wide array
of signaling receptors that recognize signals from the
microbiota as well as signals indicating tissue damage.
Several studies using genetically modified mouse models
have demonstrated the role of host innate immune com-
ponents in influencing the composition of the gut
microbiota, which modifies disease susceptibility [17].
Progress made in metagenomic sequencing has enabled
the study of host innate immune control of microbial
ecology. The findings indicate that several immune path-
ways contribute to maintaining a stable bacterial popula-
tion, which potentially supports the existence of
multiple levels of cross-talk, compensation, and comple-
mentarity in effector mechanisms of the innate immune
system that exert control over the metagenome [75].
Toll-like receptors (TLRs) were the first pattern recog-
nition receptors (PRRs) implicated in the recognition of
ligands from commensal microbiota [76]. The TLR-
induced inflammatory response is dependent on a com-
mon signaling pathway that is mediated by the adaptor
molecule myeloid differentiation primary response gene
88 (MYD88) [77]. The co-receptor of TLR4, CD14, has
been implicated in host–microbiota co-regulation in
obesity [78]. Nevertheless, the role of TLR signaling in
controlling the composition of the intestinal microbiota
remains controversial. The intestinal microbiota of Tlr5-
deficient mice and Myd88-deficient mice was described
to differ from that of wild-type mice [79, 80]. However,
another study showed that TLR signaling or MYD88 sig-
naling does not change the composition of the intestinal
microbiota under homeostatic conditions and afterrecovery from antibiotic treatment, but rather that par-
ental lineage and housing conditions of mice are critical
determinants of the microbiome [81]. This possibly im-
plicates familial transmission as an additional strong
driver of microbiome composition, which is in line with
the interpretation of results from a study of human micro-
biome composition within and across households [2].
Another family of pattern recognition receptors is the
family of NOD-like receptors (NLRs), which sense a
wide array of microbial ligands and host-derived signals
of cell damage. NOD2 has an essential role in con-
trolling the commensal bacterial community in the
intestine (Fig. 2). Analysis of intestinal microbiota of
Nod2-deficient mice revealed increased numbers of
commensal bacteria, as well as a reduced capability to
clear newly colonizing bacteria [82]. In addition to the
control of the microbiota by NOD2, bacterial colonization
was shown to induce the expression of NOD2. Mechanis-
tically, NOD2 was suggested to have an important role in
intestinal crypt function and regulate commensal micro-
biota composition and abundance through the bactericidal
activity of antimicrobial peptides secreted by the ileal
crypt. Consistently, several studies suggested that muta-
tions in Nod2 alter host–microbial interactions through
altered antimicrobial activity [83, 84].
Certain NLR proteins are capable of forming a cyto-
plasmic complex called an inflammasome [85], including
NLRP1, NLRP3, NLRC4, NLRP6, and NLRP7 [86]. Al-
though these NLR proteins have different cell-type-
specific expression patterns, all form an inflammasome
complex that mediates the secretion of the cytokines IL-
1β and IL-18, in a caspase-1 dependent manner [86].
Deficiency in the NLRP6 inflammasome, which is highly
expressed in mouse colonic epithelial cells, results in re-
duced IL-18 levels and a dysbiotic microbiota character-
ized by expanded representation of the bacterial phyla
Bacteroidetes (Prevotellaceae) and TM7 [87]. The devel-
opment of dysbiosis in NLRP6-deficient mice resulted in
exacerbation of chemical colitis induced by exposure to
dextran sodium sulfate [87], colitis-associated colorectal
cancer [88], and features of the metabolic syndrome, in-
cluding non-alcoholic fatty liver disease, morbid obesity,
and type II diabetes mellitus [89]. Co-housing of Nlrp6-
deficient mice with wild-type mice resulted in dysbiotic
microbial transfer to the recipient wild-type mice and
exacerbation of colitis, cancer, hepatic steatosis, and
obesity in the new host [87–89].
The NLRC4 inflammasome has been shown to be
activated by Gram-negative bacteria [90, 91], enteric
pathogens, including Salmonella enterica Typhimurium
and Shigella flexneri [92, 93], and more specifically by
bacterial virulence factors as well as bacterial flagellin
[92]. NLRC4 was implicated in a specific innate immune














Fig. 2 Effects of the innate and adaptive immune system on
metagenome composition. Examples of how the innate and
adaptive immune system controls microbiome composition via
effector mechanisms. NOD2-dependent secretion of anti-microbial
peptides is involved in shaping the configuration of the microbiota.
NLRP6 controls mucus secretion by goblet cells, thus having an
effect on the epithelial-proximal bacterial compartment. Regulatory T
cells orchestrate B-cell-mediated IgA secretion. The IgA repertoire, in
turn, controls bacterial targeting by the immune system and thus
metagenomic composition. IgA immunoglobin A
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NLRC4 recognizes invading pathogens in the gut,
whereas commensal bacteria remain undetected [94].
An additional link between the host genotype and gut
bacterial diversity was established when a mutation in
the MEFV gene was shown to lead to changes in the hu-
man gut microbiota [95]. Mutations in MEFV cause the
autoinflammatory disorder familial Mediterranean fever
(FMF). The MEFV gene encodes the protein pyrin/
marenostrin, which is involved in regulation of innate
immunity [96] through suppression of IL-1β activation
and abrogation of inflammation [97, 98]. Analysis of pa-
tients with FMF revealed the occurrence of significant
changes in bacterial community structure during the ac-
tive disease state [95]. These changes were characterized
by reduced total numbers of bacteria, diminished bacterial
diversity, and shifts in bacterial composition. In particular,
the proportions of Faecalibacterium and Parabacteroides
were substantially increased, whereas the proportion of
Prevotellaceae was substantially lower in patients with
acute disease than in control individuals [99]. However,
the exact molecular mechanisms behind these alterations
are not fully understood.In addition to innate immune receptors, which take
part in the communication between the host and its
microbiota by sensing microbial presence, other anti-
microbial substances can function as regulatory mole-
cules that contribute to maintaining a stable microbial
niche. Antimicrobial peptides are important effectors of
innate immunity that seem to be involved in the main-
tenance of the symbiotic environment in the gut. The
majority of antimicrobial peptides are cationic and
amphipathic, which enables them to interfere with bac-
terial membrane stability. Defensins, which are secreted
by Paneth cells of the small intestine, are particularly
abundant and widely distributed antimicrobial peptides.
The α-defensins were shown to contribute to host
defense against enteric pathogens while shaping the
composition of the small intestinal microbiota, as dem-
onstrated in a mouse model of defensin overexpression
and defensin deficiency [100, 101]. Moreover, RegIIIγ, a
secreted antibacterial lectin that specifically targets
Gram-positive bacteria, was shown to have a role in
maintaining host-microbial homeostasis by keeping the
bacteria separated from the epithelium. In RegIIIγ-
deficient mice, more bacteria reach the small intestinal
epithelium and trigger an intestinal adaptive immune re-
sponse than in control mice [102].
Adaptive immunity
In addition to the innate immune system, cells of the
adaptive immune system have been reported to partici-
pate in shaping the microbiome structure. This influ-
ence was highlighted by the consequences of the
absence of adaptive immune system cells in Rag1-
deficient mice, which have an aberrant microbial com-
munity [103]. Kawamoto et al. narrowed down the cell
types responsible for these aberrances in Rag-deficient
mice by using wild-type mice lacking T cells, which
were found to have reduced microbial diversity in the
intestine [104]. Administration of Foxp3+ regulatory T
cells to T-cell-deficient mice restored bacterial diver-
sity. This effect was dependent on the presence of
class-switched antibodies and immunoglobulin A (IgA)
selection (Fig. 2). Therefore, Foxp3+ regulatory T cells
were suggested to mediate the targeting of commensal
bacteria by IgA to maintain a homeostatic bacterial
diversity [104]. Indeed, several studies have shown that
affinity maturation, class-switch recombination and
somatic hypermutation of IgAs have a crucial role in
the regulation of bacterial composition in the intestine
[104–107].
The mechanism that controls antibody diversity is
tightly regulated by activation-induced deaminase (AID).
AID produces diversity by converting cytosine to uracil
within the immunoglobulin loci. Deficiency in AID was
shown to result in the expansion of anaerobic bacteria in
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Aid-deficient mice were analyzed using a sequencing-
based method and observed to have predominant expan-
sion of segmented filamentous bacteria throughout the
small intestine [108]. An additional study focused on the
role of somatic hypermutation in mucosal immunity by
analyzing mice with a point mutation in the Aicda gene
[107]. The mutated mice were shown to produce normal
amounts of unmutated IgA and immunoglobulin M
(IgM), which cannot efficiently recognize the intestinal
microbiota, thereby causing aberrant expansion and epi-
thelial adhesion of certain bacterial species. These findings
further corroborate the importance of AID and antibody
diversity in the maintenance of a homeostatic microbiome
(Fig. 2). Mechanistically, the selection of the plasma cell
IgA repertoire that targets the intestinal microbiota re-
quires the inhibitory co-receptor programmed cell death 1
(PD-1). PD-1 controls the number and phenotype of T fol-
licular helper cells in the germinal centers of Peyer’s
patches, which in turn control the selection of IgAs and
microbial communities in the gut [109].
Diseases of the immune system
Given the wealth of evidence for an involvement of
the immune system in shaping the microbiome during
homeostasis, it is interesting to consider whether
diseases of the immune system cause aberrations in
the composition and function of the microbiome. In
cases of severe immunomodulation by inflammatory
disease, iatrogenic intervention, or immunodeficiency,
one might find consequent changes in the microbiota.
These, in turn, may reciprocally influence the disease
process. Indeed, many such examples have been
found, including graft-versus-host disease [110], kid-
ney transplantation [111], hepatitis [112], cirrhosis
[113], psoriasis [114], IBD [115], and arthritis [116].
Furthermore, immunosuppressive drugs affect the bal-
ance between microbiota and the immune system
[117]. The effect of the immune system on the com-
position of the microbiome becomes apparent when
considering together various human conditions of im-
mune system dysfunction.
Conclusions and future directions
The intersection between metagenomics and immuno-
genomics, which has only recently begun to be ex-
plored, has fundamental importance for human health.
Although the phenomenology of the cross-regulation
of gene expression between commensal bacteria and
cells of the immune system has been established in the
past few years, our mechanistic understanding of this
relationship is still in its infancy [118]. It is now firmly
established that commensal microorganisms influence
host gene expression, in the gastrointestinal tract andin other systems, and that both microbial cell compo-
nents and secreted metabolites are involved in the
transcriptional response of the host to microbial
colonization. Nonetheless, some major questions remain.
What are the mechanisms by which microbiota-derived
molecules are integrated into the transcriptional circuits
of host cells? How is the cell-type-specificity of transcrip-
tional responses to the microbiota ensured? How does the
biogeographical localization of commensal species at dif-
ferent mucosal surfaces influence organ-specific gene
regulation? What are the kinetics of transcriptional con-
trol by the microbiota? Answering these questions would
enable the field to enter a stage in which interventional
strategies could be designed, with the goal of actively con-
trolling host transcription through harnessing the path-
ways used and the molecules secreted by commensal
microorganisms to influence host gene regulation. Such
strategies could help investigate the use of dietary modula-
tion approaches to modify the levels of microbial metabo-
lites upstream of gene regulatory circuits.
As outlined in this review, major signaling pathways of
the innate immune system are involved in shaping the
host-microbiota cross-talk during homeostasis. Interest-
ingly, genes that are part of these very pathways are
among the most frequently affected genes in common
inflammatory disorders, such as IBD [119], which
strongly suggests that a disturbed host–microbiota inter-
action is fundamentally involved in the etiology of these
diseases [115, 120]. Of note, IBD-associated micro-
biomes have consistently been reported to have low bac-
terial diversity [121], which implies that a high bacterial
diversity is a favorable condition during homeostasis and
disease.
Furthermore, although it has been established that
the host genome shapes the composition of the micro-
bial metagenome, our knowledge of the evolutionary
benefits of the microbial-driven regulation of host
gene expression remains sparse. Is adaptation of host
gene expression to the microbial status necessary for
the homeostatic maintenance of commensal commu-
nities? Which parameters characterize a 'desirable'
microbial metagenome and are selected by the host
immune system? The genomic revolution has opened
the door for such questions to be explored, and the
next decade in the study of genomic interactions
between the immune system and the microbiome will
certainly transform our understanding of the eukaryotic–
prokaryotic cross-talk that characterizes the mammalian
'super-organism'.
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